Publication:
Metastatic renal cell carcinoma to the brain: optimizing patient selection for gamma knife radiosurgery

Simple item page
dc.contributor.authorHatiboglu, M. A.
dc.contributor.authorStenman, M.
dc.contributor.authorBenmakhlouf, H.
dc.contributor.authorWersall, P.
dc.contributor.authorJohnstone, P.
dc.contributor.authorMayer-da-Silva, J.
dc.contributor.authorHarmenberg, U.
dc.contributor.authorLindskog, M.
dc.contributor.authorSinclair, G.
dc.contributor.institutionauthorHATİBOĞLU, MUSTAFA AZİZ
dc.date.accessioned2020-10-22T15:53:58Z
dc.date.available2020-10-22T15:53:58Z
dc.date.issued2020-09-01T00:00:00Z
dc.description.abstractIntroduction The effects of single-fraction gamma knife radiosurgery (sf-GKRS) on patients with renal cell carcinoma (RCC) brain metastases (BM) in the era of targeted agents (TA) and immune checkpoint inhibitors (ICI) are insufficiently studied. Methods and materials Clear cell metastatic RCC patients treated with sf-GKRS due to BM in 2005-2014 at three European centres were retrospectively analysed (n= 43). Median follow-up was 56 months. Ninety-five percent had prior nephrectomy, 53% synchronous metastasis and 86% extracranial disease at first sf-GKRS. Karnofsky performance status (KPS) ranged from 60 to 100%. Outcome measures were overall survival (OS), local control (LC) and adverse radiation effects (ARE). Results One hundred and ninety-four targets were irradiated. The median number of targets at first sf-GKRS was two. The median prescription dose was 22.0 Gy. Thirty-seven percent had repeated sf-GKRS. Eighty-eight percent received TA. LC rates at 12 and 18 months were 97% and 90%. Median OS from the first sf-GKRS was 15.7 months. Low serum albumin (HR for death 5.3), corticosteroid use pre-sf-GKRS (HR for death 5.8) and KPS < 80 (HR for death 9.1) were independently associated with worse OS. No further prognostic information was gleaned from MSKCC risk group, synchronous metastasis, age, number of BM or extracranial metastases. Other prognostic scores for BM radiosurgery, including DS-GPA, renal-GPA, LLV-SIR and CITV-SIR, again, did not add further prognostic value. ARE were seldom symptomatic and were associated with tumour volume, 10-Gy volume and pre-treatment perifocal oedema. ARE were less common among patients treated with TA within 1 month of sf-GKRS. Conclusions We identified albumin, corticosteroid use and KPS as independent prognostic factors for sf-GKRS of clear cell RCC BM. Studies focusing on the prognostic significance of albumin in sf-GKRS are rare. Further studies with a larger number of patients are warranted to confirm the above analytical outcome. Also, in keeping with previous studies, our data showed optimal rates of local tumour control and limited toxicity post radiosurgery, rendering GKRS the tool of choice in the management of RCC BM.
dc.identifier.citationStenman M., Benmakhlouf H., Wersall P., Johnstone P., Hatiboglu M. A. , Mayer-da-Silva J., Harmenberg U., Lindskog M., Sinclair G., -Metastatic renal cell carcinoma to the brain: optimizing patient selection for gamma knife radiosurgery-, ACTA NEUROCHIRURGICA, 2020
dc.identifier.doi10.1007/s00701-020-04537-w
dc.identifier.pubmed32902689
dc.identifier.scopus85090929425
dc.identifier.urihttp://hdl.handle.net/20.500.12645/23601
dc.identifier.wosWOS:000567759200003
dc.titleMetastatic renal cell carcinoma to the brain: optimizing patient selection for gamma knife radiosurgery
dc.typeArticle
dspace.entity.typePublication
local.avesis.id44a133e2-4f6f-4063-aa70-c39bee00f857
local.publication.isinternational1
relation.isAuthorOfPublicationdb1f8830-0234-4e6a-8b53-c1176e6da242
relation.isAuthorOfPublication.latestForDiscoverydb1f8830-0234-4e6a-8b53-c1176e6da242
Files
Collections
Yayınlar - Eserler